Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?
Acute coronary syndromes
MI
ST-segment elevation
coronary physiology
fractional flow reserve
index of microcirculatory resistance
microvascular resistance
Journal
Interventional cardiology (London, England)
ISSN: 1756-1485
Titre abrégé: Interv Cardiol
Pays: England
ID NLM: 101559687
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
19
11
2019
accepted:
13
01
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
Current data support the use of coronary physiology in patients with acute coronary syndrome (ACS). In patients with ST-elevation MI, the extent of myocardial damage and microvascular dysfunction create a complex conundrum to assimilate when considering clinical management and risk stratification. In this setting, the index of microcirculatory resistance emerged as an accurate tool to identify patients at risk of suboptimal myocardial reperfusion after primary percutaneous coronary intervention who may benefit from novel adjunctive therapies. In the context of non-ST-elevation ACS, coronary physiology should be carefully interpreted and often integrated with intracoronary imaging, especially in cases of ambiguous culprit lesion. Conversely, the functional assessment of bystander coronary disease is favoured by the available evidence, aiming to achieve complete revascularisation. Based on everyday clinical scenarios, the authors illustrate the available evidence and provide recommendations for the functional assessment of infarct-related artery and non-culprit lesions in patients with ACS.
Identifiants
pubmed: 32577130
doi: 10.15420/icr.2019.26
pmc: PMC7301203
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e05Informations de copyright
Copyright © 2020, Radcliffe Cardiology.
Déclaration de conflit d'intérêts
Disclosure: RS has served on an advisory board for Abbott. AB has received institutional funding for an interventional fellowship from Boston Scientific. All other authors have no conflicts of interest to declare.
Références
Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1063-1074
pubmed: 29446567
JAMA Cardiol. 2019 Aug 1;4(8):736-744
pubmed: 31268466
Eur Heart J. 2015 Dec 1;36(45):3165-77
pubmed: 26254178
JACC Cardiovasc Interv. 2011 Nov;4(11):1183-9
pubmed: 22115657
Int J Cardiol. 2017 Sep 15;243:40-46
pubmed: 28610962
Pharmacol Res. 2013 Nov;77:22-9
pubmed: 23994209
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
JACC Cardiovasc Interv. 2010 Dec;3(12):1274-81
pubmed: 21232721
J Am Coll Cardiol. 2016 Sep 13;68(11):1181-1191
pubmed: 27609680
JACC Cardiovasc Imaging. 2019 May;12(5):837-848
pubmed: 29680355
J Am Heart Assoc. 2017 Nov 7;6(11):
pubmed: 29113999
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2528-2535
pubmed: 29198461
Heart. 2007 Oct;93(10):1231-7
pubmed: 17395671
N Engl J Med. 2007 May 3;356(18):1823-34
pubmed: 17476008
Circ Cardiovasc Interv. 2018 Feb;11(2):e006023
pubmed: 29449325
Lancet. 2015 Aug 15;386(9994):665-71
pubmed: 26347918
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1848-1858
pubmed: 30236358
Cardiovasc Revasc Med. 2019 Dec;20(12):1148-1155
pubmed: 30797759
J Am Heart Assoc. 2019 May 7;8(9):e011534
pubmed: 31014181
Circ Cardiovasc Interv. 2015 Aug;8(8):e002207
pubmed: 26253733
Eur Heart J. 2015 Jan 7;36(2):100-11
pubmed: 25179764
Expert Rev Cardiovasc Ther. 2019 Feb;17(2):111-126
pubmed: 30569773
Circ Cardiovasc Interv. 2013 Jun;6(3):231-6
pubmed: 23756697
EuroIntervention. 2018 Jun 08;14(3):e352-e359
pubmed: 29792403
JAMA. 2014 Nov 19;312(19):2019-27
pubmed: 25399277
JAMA. 2019 Jan 1;321(1):56-68
pubmed: 30620371
Catheter Cardiovasc Interv. 2019 Nov 1;94(5):686-692
pubmed: 30912257
Eur Heart J. 2017 Mar 14;38(11):774-784
pubmed: 27354052
N Engl J Med. 2017 Mar 30;376(13):1234-1244
pubmed: 28317428
J Am Coll Cardiol. 2014 Nov 4;64(18):1894-904
pubmed: 25444143
N Engl J Med. 2019 Oct 10;381(15):1411-1421
pubmed: 31475795
Int J Cardiol. 2019 Oct 1;292:162-165
pubmed: 31029497
EuroIntervention. 2020 Apr 03;15(18):e1594-e1601
pubmed: 31543501
J Am Coll Cardiol. 2009 Sep 15;54(12):1065-71
pubmed: 19744615
J Am Heart Assoc. 2019 Jul 16;8(14):e013361
pubmed: 31284819
Circulation. 2016 Dec 6;134(23):1833-1847
pubmed: 27803036
Circulation. 2003 Jul 1;107(25):3129-32
pubmed: 12821539
Rev Esp Cardiol (Engl Ed). 2018 Nov;71(11):986-988
pubmed: 28928070
Int J Cardiol. 2015 Jan 15;178:46-54
pubmed: 25464218
Am Heart J. 2017 Nov;193:63-69
pubmed: 29129256
J Am Coll Cardiol. 2016 Oct 11;68(15):1708-1709
pubmed: 27712788
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1437-1449
pubmed: 30093050
JAMA Cardiol. 2017 Jun 1;2(6):699-700
pubmed: 28273298
Curr Opin Cardiol. 2017 Nov;32(6):767-775
pubmed: 28799978